StockWatch
·
Specialty Chemicals
Board Meeting14 Jul 2026, 06:00 pm

Daikaffil Chemicals Approves Revised Consolidated Financial Results for FY26

AI Summary

Daikaffil Chemicals India Ltd's Board of Directors met on July 14, 2026, to approve revised audited consolidated financial results for the quarter and financial year ended March 31, 2026. The revision solely incorporates the Consolidated Statement of Cash Flows, with no changes to the previously approved financial performance or position from the May 28, 2026, announcement. The company also noted a communication from BSE regarding a fine for the initial non-submission of the cash flow statement. The revised results, including the auditors' unmodified opinion, will be published and available on the company and BSE websites.

Key Highlights

  • Board approved revised audited consolidated financial results for FY26.
  • Revision includes Consolidated Statement of Cash Flows only.
  • No change in financial performance from prior results.
  • BSE communication regarding fine for non-submission noted.
  • Auditors issued an unmodified opinion on the revised results.